219 related articles for article (PubMed ID: 23708123)
1. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
[TBL] [Abstract][Full Text] [Related]
3. Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.
Eltahla AA; Tay E; Douglas MW; White PA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7215-24. PubMed ID: 25246395
[TBL] [Abstract][Full Text] [Related]
4. RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs.
Waheed Y; Bhatti A; Ashraf M
Infect Genet Evol; 2013 Mar; 14():247-57. PubMed ID: 23291407
[TBL] [Abstract][Full Text] [Related]
5. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
Wang YK; Rigat KL; Roberts SB; Gao M
Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
[TBL] [Abstract][Full Text] [Related]
6. Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.
Musiu S; Pürstinger G; Stallinger S; Vrancken R; Haegeman A; Koenen F; Leyssen P; Froeyen M; Neyts J; Paeshuyse J
Antiviral Res; 2014 Jun; 106():71-9. PubMed ID: 24680957
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
8. Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluation.
Lin YT; Huang KJ; Tseng CK; Chen KJ; Wang HM; Lee JC
Assay Drug Dev Technol; 2011 Jun; 9(3):290-8. PubMed ID: 21281131
[TBL] [Abstract][Full Text] [Related]
9. A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.
Madhvi A; Hingane S; Srivastav R; Joshi N; Subramani C; Muthumohan R; Khasa R; Varshney S; Kalia M; Vrati S; Surjit M; Ranjith-Kumar CT
Sci Rep; 2017 Jul; 7(1):5816. PubMed ID: 28725041
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of active hepatitis C virus RNA-dependent RNA polymerase.
Ryu K; Kim KH; Yoo SY; Lee EY; Lim KH; Min MK; Kim H; Choi SI; Seong BL
Protein Expr Purif; 2010 Jun; 71(2):147-52. PubMed ID: 20060472
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A
Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620
[TBL] [Abstract][Full Text] [Related]
12. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
[TBL] [Abstract][Full Text] [Related]
13. Structure-based inhibition of Norovirus RNA-dependent RNA polymerases.
Mastrangelo E; Pezzullo M; Tarantino D; Petazzi R; Germani F; Kramer D; Robel I; Rohayem J; Bolognesi M; Milani M
J Mol Biol; 2012 Jun; 419(3-4):198-210. PubMed ID: 22446684
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside inhibitors of the HCV polymerase.
Sarisky RT
J Antimicrob Chemother; 2004 Jul; 54(1):14-6. PubMed ID: 15190019
[TBL] [Abstract][Full Text] [Related]
16. A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase.
Lee JC; Tseng CK; Chen KJ; Huang KJ; Lin CK; Lin YT
Anal Biochem; 2010 Aug; 403(1-2):52-62. PubMed ID: 20382106
[TBL] [Abstract][Full Text] [Related]
17. B-ring modified aurones as promising allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Meguellati A; Ahmed-Belkacem A; Yi W; Haudecoeur R; Crouillère M; Brillet R; Pawlotsky JM; Boumendjel A; Peuchmaur M
Eur J Med Chem; 2014 Jun; 80():579-92. PubMed ID: 24835816
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
19. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.
Jones LA; Clancy LE; Rawlinson WD; White PA
Antimicrob Agents Chemother; 2006 Sep; 50(9):3019-27. PubMed ID: 16940097
[TBL] [Abstract][Full Text] [Related]
20. Broad-spectrum non-nucleoside inhibitors for caliciviruses.
Netzler NE; Enosi Tuipulotu D; Eltahla AA; Lun JH; Ferla S; Brancale A; Urakova N; Frese M; Strive T; Mackenzie JM; White PA
Antiviral Res; 2017 Oct; 146():65-75. PubMed ID: 28757394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
